These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15243398)

  • 41. Severe but reversible hepatitis induced by troglitazone.
    Schiano T; Dolehide K; Hart J; Baker AL
    Dig Dis Sci; 2000 May; 45(5):1039-42. PubMed ID: 10795774
    [No Abstract]   [Full Text] [Related]  

  • 42. [A new case: pioglitazone hepatotoxicity].
    Martínez Odriozola P; Ibarmia Lahuerta J; Gutiérrez Macías A; de la Villa FM
    Med Clin (Barc); 2007 Jun; 129(4):158-9. PubMed ID: 17663974
    [No Abstract]   [Full Text] [Related]  

  • 43. [Pioglitazone].
    Kobayashi M; Iwata M; Hiratani K
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():429-37. PubMed ID: 12387029
    [No Abstract]   [Full Text] [Related]  

  • 44. Pioglitazone is a valid alternative to rosiglitazone.
    Derosa G
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):357-62. PubMed ID: 21950735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thiazolidinediones in diabetes: current status and future outlook.
    Camp HS
    Curr Opin Investig Drugs; 2003 Apr; 4(4):406-11. PubMed ID: 12808879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Doubts as to the cardiovascular safety of rosiglitazone].
    Hoekstra JB; Bossuyt PM; de Vries JH
    Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1449-50. PubMed ID: 17633972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between plasma hANP level and pretibial edema by pioglitazone treatment.
    Kahara T; Takamura T; Misaki T; Sakurai M; Takeshita Y; Shimizu A; Kaneko S
    Endocr J; 2005 Jun; 52(3):373-6. PubMed ID: 16006733
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular risk and TZD: safe therapy for the elderly?
    Burt R; Townsend S; Armor B
    Consult Pharm; 2009 May; 24(5):392-4. PubMed ID: 19555148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The safety of thiazolidinediones.
    Tolman KG
    Expert Opin Drug Saf; 2011 May; 10(3):419-28. PubMed ID: 21366501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thiazolidinediones.
    Mascitelli L; Pezzetta F
    N Engl J Med; 2005 Jan; 352(2):205-7; author reply 205-7. PubMed ID: 15651125
    [No Abstract]   [Full Text] [Related]  

  • 51. Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects.
    Pfützner A; Weber MM; Forst T
    Expert Opin Pharmacother; 2007 Aug; 8(12):1985-98. PubMed ID: 17696799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. REVISITING THE USE OF PIOGLITAZONE IN THE TREATMENT OF TYPE 2 DIABETES.
    Einhorn D; Fonseca V
    Endocr Pract; 2016 Nov; 22(11):1343-1346. PubMed ID: 27540881
    [No Abstract]   [Full Text] [Related]  

  • 53. Type 2 diabetes, thiazolidinediones: bad to the bone?
    Watts NB; D'Alessio DA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3276-8. PubMed ID: 16960122
    [No Abstract]   [Full Text] [Related]  

  • 54. Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy.
    May LD; Lefkowitch JH; Kram MT; Rubin DE
    Ann Intern Med; 2002 Mar; 136(6):449-52. PubMed ID: 11900497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin Resistance Intervention After Stroke Trial of Pioglitazone: Is This Perhaps the End of the Beginning?
    Ntaios G; Kent TA
    Stroke; 2016 Jul; 47(7):1962-4. PubMed ID: 27222525
    [No Abstract]   [Full Text] [Related]  

  • 56. Long-term safety of pioglitazone versus glyburide in patients with recently diagnosed type 2 diabetes mellitus.
    Jain R; Osei K; Kupfer S; Perez AT; Zhang J
    Pharmacotherapy; 2006 Oct; 26(10):1388-95. PubMed ID: 16999648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thiazolidinediones: the Forgotten Diabetes Medications.
    Lebovitz HE
    Curr Diab Rep; 2019 Nov; 19(12):151. PubMed ID: 31776781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies of diabetes, thiazolidinediones, and coronary heart disease.
    Walker AM; McAfee AT; Koro C
    Pharmacoepidemiol Drug Saf; 2007 Dec; 16(12):1313-4; author reply 1314-6. PubMed ID: 18041104
    [No Abstract]   [Full Text] [Related]  

  • 59. Pioglitazone hydrochloride/glimepiride.
    Blake EW
    Drugs Today (Barc); 2007 Jul; 43(7):487-97. PubMed ID: 17728849
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness and side effects of thiazolidinediones for type 2 diabetes.
    Arnold N; McLean M; Chipps DR; Cheung NW
    Med J Aust; 2005 May; 182(9):494. PubMed ID: 15999431
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.